With the outbreak of the Covid-19 virus which has had a global impact, disrupting not only economies but proving to be one of the grave challenges the health sector has been faced with.
Taking that there is still no cure or vaccine for the Covid-19 virus, scientists as well as researchers from various parts of the world have started preliminary work on a coronavirus vaccine.
South Africa has started work on the development of a vaccine for the Covid-19 virus, Higher Education Minister Blade Nzimande has said.
This project is being taken on by the University of Cape Town together with the Council for Scientific and Industrial Research as well as the Biological and Vaccines Institute of Southern Africa.
In a response following President Cyril Ramaphosa‘s announcement of a 21-day lockdown to curb the spread of the virus, Nzimande said a number of existing drugs was currently being re-purposed and tested for efficacy, adding current international trials under the co-ordination of the World Health Organisation were being monitored.
Nzimande further added that “Progress is expected in about 18 months”
“The South African Centre for Epidemiological Modelling and Analysis has been engaging with other data and modelling groups to refine its assumptions to produce an updated model of the spread of the virus.
This is expected to be completed by friday, Nzimande said.
In terms of diagnostic tools, he added it had become urgent to locally manufacture reagents for testing kits.
“These are currently being imported and the lockdown may threaten access to supplies.”
“The Department of Science and Innovation has negotiated the re-purposing of various facilities and labs to respond to the outbreak. The entities in line to assist include Biovac, Centres of Excellence in TB Research, Centre of Proteomic and Genomic Research and Afrigen Bio.”
“Discussions are underway to facilitate accreditation for some of the facilities to produce reagents. The team will be discussing budget requirements this afternoon.”
“For the above projects, the Department of Science and Innovation has already availed R12-million and will redirect an additional R30-million.”